Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Crispr Therapeutics Ag (CRSP)

Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,397,388
  • Shares Outstanding, K 84,918
  • Annual Sales, $ 371,210 K
  • Annual Income, $ -153,610 K
  • 60-Month Beta 1.78
  • Price/Sales 14.93
  • Price/Cash Flow N/A
  • Price/Book 2.66
Trade CRSP with:

Options Overview Details

View History
  • Implied Volatility 53.24% ( -0.47%)
  • Historical Volatility 46.95%
  • IV Percentile 22%
  • IV Rank 26.72%
  • IV High 96.14% on 10/06/23
  • IV Low 37.60% on 09/14/23
  • Put/Call Vol Ratio 0.28
  • Today's Volume 5,478
  • Volume Avg (30-Day) 5,659
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 97,830
  • Open Int (30-Day) 91,831

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -1.37
  • Number of Estimates 13
  • High Estimate 0.00
  • Low Estimate -1.98
  • Prior Year -0.98
  • Growth Rate Est. (year over year) -39.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.52 +21.02%
on 05/29/24
67.88 -6.36%
on 06/13/24
+7.85 (+14.09%)
since 05/14/24
3-Month
51.02 +24.58%
on 05/10/24
75.91 -16.27%
on 03/21/24
-8.45 (-11.73%)
since 03/14/24
52-Week
37.55 +69.27%
on 10/23/23
91.10 -30.23%
on 02/22/24
+4.60 (+7.80%)
since 06/14/23

Most Recent Stories

More News
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought

These companies could generate explosive growth over time.

VRTX : 480.73 (+0.35%)
ARKG : 25.05 (-2.83%)
CRSP : 63.56 (-2.60%)
NTLA : 25.15 (-3.12%)
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?

In keeping with Cathie Wood's style, these picks are riskier than average.

ARKK : 43.87 (-1.15%)
CRSP : 63.56 (-2.60%)
NTLA : 25.15 (-3.12%)
3 Cathie Wood Biotech Stocks That Analysts Expect to Double

This article delves into three biotech stocks held in Cathie Wood's ARKK ETF that analysts expect to double in value. Investors looking to add exposure to promising biotech opportunities, with a preference...

ARKK : 43.87 (-1.15%)
NTLA : 25.15 (-3.12%)
PRME : 7.11 (-10.00%)
BEAM : 24.87 (-1.47%)
XBI : 91.75 (-2.21%)
WFC : 57.40 (+0.23%)
VKTX : 52.02 (-0.15%)
CRSP : 63.56 (-2.60%)
ABBV : 168.59 (+1.22%)
AMGN : 298.62 (+0.04%)
BMY : 41.20 (-0.68%)
GILD : 65.06 (+2.36%)
Cathie Wood Has Been Steadily Selling Shares of This Growth Stock. Should You?

Teladoc's share performance has reflected its earnings struggles...

TSLA : 178.01 (-2.44%)
CRSP : 63.56 (-2.60%)
ARKK : 43.87 (-1.15%)
ARKG : 25.05 (-2.83%)
TDOC : 10.00 (+0.50%)
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow

There are a handful of different factors that could buoy its stock.

CRSP : 63.56 (-2.60%)
Is CRISPR Therapeutics a Millionaire Maker?

The stars are aligning for it to be a leader for years to come.

CRSP : 63.56 (-2.60%)
Bull Market Buys: 2 Growth Stocks to Own for the Long Run

These biotech stocks have just launched their first products.

RJF : 115.67 (-1.33%)
CRSP : 63.56 (-2.60%)
IOVA : 8.16 (-3.20%)
Is CRISPR Therapeutics Stock a Buy?

The gene-editing therapy specialist is rising in prominence.

CRSP : 63.56 (-2.60%)
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.

How much would you pay for a stock that might earn $25 a year in six years?

CRSP : 63.56 (-2.60%)
VRTX : 480.73 (+0.35%)
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential

These healthcare stocks offer completely different approaches to long-term investment gains.

PFE : 27.53 (-0.43%)
CRSP : 63.56 (-2.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

CRISPR Therapeutics AG is a leading gene editing company focused on developing CRISPR/Cas9-based therapeutics. The company is rapidly leveraging its CRISPR/Cas9 gene-editing platform to make therapies for the treatment of hemoglobinopathies, cancer, diabetes and other diseases.

See More

Key Turning Points

3rd Resistance Point 66.70
2nd Resistance Point 66.04
1st Resistance Point 64.80
Last Price 63.56
1st Support Level 62.90
2nd Support Level 62.25
3rd Support Level 61.01

See More

52-Week High 91.10
Fibonacci 61.8% 70.64
Fibonacci 50% 64.32
Last Price 63.56
Fibonacci 38.2% 58.01
52-Week Low 37.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar